Navigation Links
BD Announces FDA 510(k) Clearance of Two-Hour Test to Identify Superbug in Patients with Positive Blood Cultures
Date:1/3/2008

First Molecular Test to Simultaneously Identify Staphylococcus aureus and Methicillin-Resistant Staphylococcus aureus from Positive Blood Cultures

SAN DIEGO, Jan. 2 /PRNewswire-FirstCall/ -- BD Diagnostics, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), announced today that it received clearance from the U.S. Food and Drug Administration (FDA) for the BD GeneOhm(TM) StaphSR assay. This new assay is the first test available to rapidly and simultaneously identify two deadly healthcare-associated infections (HAIs) -- Staphylococcus aureus (SA) and methicillin-resistant Staphylococcus aureus (MRSA) -- from patients with positive blood cultures. It will help enable physicians to implement the right treatment at the right time for patients with bloodstream infections, thereby transforming patient care and significantly reducing healthcare costs.

"The BD GeneOhm StaphSR assay provides a rapid, definitive identification of SA and MRSA from blood cultures. This allows for more appropriate isolation procedures and agent-specific antimicrobial therapy, resulting in reduced patient morbidity and mortality as well as an overall reduction in healthcare costs," said Thomas Davis, M.D., Ph.D., Director of Clinical Microbiology, Wishard Memorial Hospital, Indianapolis, Indiana.

"The launch of the BD GeneOhm StaphSR assay in the United States further demonstrates BD's commitment to helping healthcare providers rapidly identify, prevent and control HAIs," said Vince Forlenza, Executive Vice President, BD. "It also illustrates our desire to provide customers with a complete menu of assays and tools to combat these potentially deadly infections."

The BD GeneOhm StaphSR assay provides results within two hours, directly f
'/>"/>

SOURCE BD
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... 27, 2015  PTC Therapeutics, Inc. (NASDAQ: ... financial results for the fourth quarter and full year ... a transformative year for PTC. We are now a ... RNA-targeted therapies in the rare disease space," stated Stuart ... "We are proud to bring the first treatment for ...
(Date:2/27/2015)... JERUSALEM , Feb. 27, 2015 /PRNewswire/ ... capsules, its lead product for the orphan condition acromegaly, ... E financing round. Participants in the financing included new ... undisclosed blue chip public investment fund, as well as ... Ventures, Abingworth and ARCH Venture Partners. ...
(Date:2/26/2015)... CHICAGO, Ill. , Feb. 26, 2015 /PRNewswire/ ... that 15 abstracts of studies in its neuroscience ... presentation during the 67 th American Academy ... D.C. , from April 18-25. The accepted ... product, DUOPA, in addition to investigational treatments in ...
Breaking Medicine Technology:PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 2PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 3PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 4PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 5PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 6PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 7PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 8PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 9PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 10PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 11Chiasma Announces Completion of $70 Million Series E Financing 2Chiasma Announces Completion of $70 Million Series E Financing 3AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 2AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 3AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 4AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 5AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 6AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 7
... grant awarded by NIH; Findings could benefit,pregnant women ... Institute of,Child Health and Human Development division of ... A. Williams, Sc.D., a $2.9 million grant,for a ... the,serious pregnancy complication known as preeclampsia and migraine., ...
... of cost-effective and rapidly deployed ... vaccine solution for avian and seasonal flu, ROCKVILLE, ... announced today its recognition at the annual meeting of ... an H5N1 avian influenza vaccine and a seasonal influenza ...
Cached Medicine Technology:Swedish in Seattle to Study Connections Between Preeclampsia and Migraine 2Swedish in Seattle to Study Connections Between Preeclampsia and Migraine 3NOVAVAX Featured at Clinton Global Initiative 2008 Annual Meeting 2NOVAVAX Featured at Clinton Global Initiative 2008 Annual Meeting 3
(Date:3/1/2015)... ERISAPros is pleased to ... to the professional staff of its Compliance Department. , ... Ohio State University-Mortiz College of Law. Prior to joining ... with several Fortune 500 companies as well as several ... benefits. Her experiences range from benefit plan design, vendor ...
(Date:3/1/2015)... WA (PRWEB) February 28, 2015 CrossFit Attollo ... spring they are offering a special discount to new members. ... sign up for a three month contract will receive their ... month individually would cost members $440. The three month ... per month, and then the fourth month comes in at ...
(Date:2/28/2015)... 01, 2015 Heart diseases are on ... percent of urban adult population and 5 percent of ... diseases and 20-30 percent of them require specialized investigation ... and coronary vascular diseases (CVD). , A division of ... market research report titled “Indian Coronary Stent Market Forecast ...
(Date:2/28/2015)... 2015 With their commitment to achieving ... an additional exercise to their already robust library of ... most commonly known as, is often performed on a ... executed in a relatively safe manner and can be ... The full description of “Rope Pulls” is located in ...
(Date:2/28/2015)... 28, 2015 March—also known as ... to remind ourselves and others that suspected head ... NeuroSurgical Specialists (ANS). , Concussions are a form ... 75% of TBIs. There are 1.6-3.8 million sports-related ... benign, but it is a brain injury. Many ...
Breaking Medicine News(10 mins):Health News:ERISAPros Recruits Evelyn King, J.D. and Carolyn Roddy, J.D. to its Professional Staff 2Health News:CrossFit Gym in Vancouver WA Offers Spring Special 2Health News:India Coronary Stent Market 2019 Forecasts Analysis in New Research Report Available at MarketReportsOnline.com 2Health News:India Coronary Stent Market 2019 Forecasts Analysis in New Research Report Available at MarketReportsOnline.com 3Health News:Atlantic NeuroSurgical Specialists (ANS) Focus on National Brain Injury Awareness Month to Educate the General Public on Head Trauma 2Health News:Atlantic NeuroSurgical Specialists (ANS) Focus on National Brain Injury Awareness Month to Educate the General Public on Head Trauma 3
... patients with a form of epilepsy , , TUESDAY, Oct. ... associated with a high risk for complications and even death ... researchers at the Mayo Clinic in Rochester, Minn. , The ... prolonged seizures that don,t respond to initial treatment. The condition ...
... lung cancer called video-assisted thoracic surgery or VATS is ... centers. Now, a preliminary study to be presented ... is giving surgeons an early look at its benefits. ... a six to 10-inch incision, cutting the major muscles ...
... "They said one pink,bus couldn,t change a ... for,Breast Health Education,s message on the side of ... starting next week. The bus will promote the,"Size ... http://www.newscom.com/cgi-bin/prnh/20081028/DC42054 ), October is National ...
... 2008A team of Universit Laval researchers has shown that the ... brains of mice fed a diet rich in animal fat ... diets typical of most industrialized countries promote the development of ... of Aging . , To demonstrate this, the team led ...
... annual mammograms and breast self-examination during National Breast Cancer Awareness ... cautious when getting a mammogram. , ... ... premier online destination for personal image enhancement solutions, is pleased ...
... Society of Plastic Surgeons Annual Meeting, CHICAGO, ... born with a rare congenital deformity who turned ... the proud recipient of,the 2008 Patients of Courage: ... Plastic Surgeons (ASPS) Plastic Surgery 2008 conference,Saturday, November ...
Cached Medicine News:Health News:Sedative Could Be Deadly in People With Seizures 2Health News:Highly specialized, minimally invasive surgery for lung cancer allows patient to go home sooner 2Health News:The Maurer Foundation Promotes Breast Health Message With Unique Traveling Pink Bus 2Health News:A high-fat diet could promote the development of Alzheimer's 2Health News:Women with Breast Implants Encouraged To Go Beyond Regular Mammogram Screening 2Health News:Women with Breast Implants Encouraged To Go Beyond Regular Mammogram Screening 3Health News:Women with Breast Implants Encouraged To Go Beyond Regular Mammogram Screening 4Health News:Towson Student Wins Courage Award, Turns Facial Differences Into Positive Tool 2
Gold Labeling kit for antibodies, the Coat-Block-Run Conjugation Kit pH 5-8; contains 1 bottle each of 20 nm and 40 nm Naked Gold...
Colloidal Gold Conjugated, Goat anti-mouse IgG (H&L) - 12 OD...
Colloidal Gold Conjugated, Goat anti-mouse IgG (H&L) - 50 OD...
Colloidal Gold Conjugated, Goat anti-human IgM (Mu Chain) - 12 OD...
Medicine Products: